Hims & Hers CFO sells 11,592 shares at $57.1275 avg

Hims & Hers Health (HIMS) reported an insider transaction by its Chief Financial Officer.

Rhea-AI Filing Summary

Hims & Hers Health (HIMS) reported an insider transaction by its Chief Financial Officer. On 10/17/2025, the CFO exercised stock options for 7,785 shares at $5.01 and 3,807 shares at $11.53, then sold 11,592 Class A shares at a weighted average price of $57.1275. These trades were made under a Rule 10b5-1 trading plan adopted on May 21, 2025.

Following the transactions, the CFO beneficially owned 70,232 Class A shares directly. Derivative holdings following the transactions included 174,380 options (exercise price $5.01; expiration 02/23/2032) and 56,169 options (exercise price $11.53; expiration 03/01/2033).

Insider Trade Summary

Exercise and Sale: 11,592 shares ($579K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider Okupe Oluyemi

Role Chief Financial Officer

Sold 11,592 shs ($662K)

Approx. gross sale proceeds $662K

Approx. exercise cost $83K

Approx. pre-tax spread $579K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	7,785	$0.00	$0.00
Exercise	Stock Option (right to buy)	3,807	$0.00	$0.00
Exercise	Class A Common Stock	7,785	$5.01	$39K
Exercise	Class A Common Stock	3,807	$11.53	$44K
Sale	Class A Common Stock	11,592	$57.1275	$662K

Holdings After Transaction: Stock Option (right to buy) — 230,549 contracts (Direct); Class A Common Stock — 70,232 shares (Direct)

Footnotes (4)

1. F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
2. F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.93 - $57.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3. F3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
4. F4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HIMS disclose in this Form 4?

The CFO exercised options for 7,785 shares at $5.01 and 3,807 shares at $11.53 on 10/17/2025, then sold 11,592 shares at a $57.1275 weighted average.

Was the HIMS CFO’s trade under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 plan adopted on May 21, 2025.

How many HIMS shares did the CFO sell and at what price?

11,592 Class A shares at a weighted average price of $57.1275, with sales between $56.93 and $57.315.

How many HIMS shares does the CFO own after these transactions?

70,232 Class A shares directly, following the reported transactions.

What derivative securities remain after the transactions?

174,380 options at $5.01 expiring 02/23/2032 and 56,169 options at $11.53 expiring 03/01/2033.

What is the earliest transaction date on the Form 4 for HIMS?

10/17/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/20/2025 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/17/2025		M(1)		7,785	A	$5.01	78,017	D
Class A Common Stock	10/17/2025		M(1)		3,807	A	$11.53	81,824	D
Class A Common Stock	10/17/2025		S(1)		11,592	D	$57.1275(2)	70,232	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	10/17/2025		M(1)			7,785	(3)	02/23/2032	Class A Common Stock	7,785	$0	174,380	D
Stock Option (right to buy)	$11.53	10/17/2025		M(1)			3,807	(4)	03/01/2033	Class A Common Stock	3,807	$0	56,169	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.93 - $57.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

3. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.

4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	10/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.